EIB PLOTS BACKING FOR PIERRE FABRE EXPANSION
September 1st, 2011
BY KEITH NUTHALL
THE EUROPEAN Investment Bank (EIB) is planning to lend French pharmaceutical company Pierre Fabre up to Euro EUR125 million. The money would help it research and develop medicines for oncology, central nervous systems, cardio-vascular issues, immunology and dermatology. This money would come from an EIB-European Commission 'Risk Sharing Finance Facility' helping innovators.
ENDS
THE EUROPEAN Investment Bank (EIB) is planning to lend French pharmaceutical company Pierre Fabre up to Euro EUR125 million. The money would help it research and develop medicines for oncology, central nervous systems, cardio-vascular issues, immunology and dermatology. This money would come from an EIB-European Commission 'Risk Sharing Finance Facility' helping innovators.
ENDS
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.